Extracts of dietary plants are efficient modulators of nuclear factor kappa B

Food and Chemical Toxicology

Volumn 46, Issue 4, 2008, Pages 1288-1297

  Paur, I ^a   Austenaa, L M ^a   Blomhoff, R ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Diet; Inhibitor; NF B; Phytochemicals

Indexed keywords

ACETYLCYSTEINE; APIGENIN; CAPSAICIN; CARNOSOL; COUMARIN; CURCUMIN; DEXAMETHASONE; EPICATECHIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; RUTOSIDE; SULFORAPHANE; THYMOL; TURMERIC;

ARTICLE; CELL CULTURE; CELL STRESS; CHEMOPROPHYLAXIS; CLOVE; COFFEE; DIETARY INTAKE; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FOOD COMPOSITION; NONHUMAN; OREGANO; OXIDATION REDUCTION POTENTIAL; THYME;

CELL LINE; DNA; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; HUMANS; LIPOPOLYSACCHARIDES; LUCIFERASES; MONOCYTES; NF-KAPPA B; OXIDATION-REDUCTION; PLANT EXTRACTS; PLANTS, EDIBLE; REFERENCE STANDARDS; TRANSCRIPTION FACTOR RELA; TRANSFECTION; U937 CELLS;

EID: 39149106177     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.09.103     Document Type: Article

References (53)

1. American Institute for Cancer Research/World Cancer Research Fund, 1997. Food, Nutrition and the Prevention of Cancer: a global perspective.
2. Atalay M., Gordillo G., Roy S., Rovin B., Bagchi D., Bagchi M., and Sen C.K. Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett. 544 1-3 (2003) 252-257
3. Austenaa L.M., Carlsen H., Ertesvag A., Alexander G., Blomhoff H.K., and Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J. 18 11 (2004) 1255-1257
4. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal. Biochem. 239 1 (1996) 70-76
5. Blomhoff R. Dietary antioxidants and cardiovascular disease. Curr. Opin. Lipidol. 16 1 (2005) 47-54
6. Blondeau N., Widmann C., Lazdunski M., and Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J. Neurosci. 21 13 (2001) 4668-4677
7. Carlsen H., Moskaug J.O., Fromm S.H., and Blomhoff R. In vivo imaging of NF-kappa B activity. J. Immunol. 168 3 (2002) 1441-1446
8. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5 5 (2004) 392-401
9. Christman J.W., Sadikot R.T., and Blackwell T.S. The role of nuclear factor-kappa B in pulmonary diseases. Chest 117 5 (2000) 1482-1487
10. Dragland S., Senoo H., Wake K., Holte K., and Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J. Nutr. 133 5 (2003) 1286-1290
11. Eliseev R.A., Vanwinkle B., Rosier R.N., and Gunter T.E. Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFkappaB. J. Biol. Chem. 279 45 (2004) 46748-46754
12. Feldmann M., Andreakos E., Smith C., Bondeson J., Yoshimura S., Kiriakidis S., Monaco C., Gasparini C., Sacre S., Lundberg A., Paleolog E., Horwood N.J., Brennan F.M., and Foxwell B.M. Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?. Ann. Rheum. Dis. 61 Suppl 2 (2002) ii13-ii18
13. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., and Packer L. Redox regulation of NF-kappa B activation, Free Radic. Biol. Med. 22 6 (1997) 1115-1126
14. Gilmore T.D., and Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25 51 (2006) 6887-6899
15. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., and Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 3 (2004) 285-296
16. Greten F.R., and Karin M. The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett. 206 2 (2004) 193-199
17. Halliwell B. The antioxidant paradox. Lancet 355 9210 (2000) 1179-1180
18. Halvorsen B.L., Carlsen M.H., Phillips K.M., Bohn S.K., Holte K., Jacobs Jr. D.R., and Blomhoff R. Content of redox-active compounds (ie, antioxidants) in foods consumed in the United States. Am. J. Clin. Nutr. 84 1 (2006) 95-135
19. Halvorsen B.L., Holte K., Myhrstad M.C., Barikmo I., Hvattum E., Remberg S.F., Wold A.B., Haffner K., Baugerod H., Andersen L.F., Moskaug O., Jacobs Jr. D.R., and Blomhoff R. A systematic screening of total antioxidants in dietary plants. J. Nutr. 132 3 (2002) 461-471
20. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 22 13 (2003) 3356-3366
21. Huang C., Huang Y., Li J., Hu W., Aziz R., Tang M.S., Sun N., Cassady J., and Stoner G.D. Inhibition of benzo (a) pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res. 62 23 (2002) 6857-6863
22. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 4 (2002) 301-310
23. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 10 (2005) 749-759
24. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappaB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 1 (2004) 17-26
25. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., and Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 91 1 (2006) 123-131
26. Lee J., Jung E., Kim Y., Lee J., Park J., Hong S., Hyun C.G., Park D., and Kim Y.S. Rosmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3. Br. J. Pharmacol. 148 3 (2006) 366-375
27. Li Q., and Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol 2 10 (2002) 725-734
28. Luo J.L., Kamata H., and Karin M. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115 10 (2005) 2625-2632
29. Luo J.L., Maeda S., Hsu L.C., Yagita H., and Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6 3 (2004) 297-305
30. Mattson M.P., and Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest 107 3 (2001) 247-254
31. Muller M., and Kersten S. Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4 4 (2003) 315-322
32. Nakanishi C., and Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 5 4 (2005) 297-309
33. Neurath M.F., Becker C., and Barbulescu K. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43 6 (1998) 856-860
34. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 49 (1999) 6853-6866
35. Pergola C., Rossi A., Dugo P., Cuzzocrea S., and Sautebin L. Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Nitric Oxide 15 1 (2006) 30-39
36. Philip S., and Kundu G.C. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem. 278 16 (2003) 14487-14497
37. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 7007 (2004) 461-466
38. Plummer S.M., Holloway K.A., Manson M.M., Munks R.J., Kaptein A., Farrow S., and Howells L. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18 44 (1999) 6013-6020
39. Report of a joint FAO/WHO Expert Consultation, 2003. Diet, Nutrition and the Prevention of Chronic Diseases, WHO Technical Report Series, Geneva, No. 916.
40. Ricciardi R., Shah S.A., Wheeler S.M., Quarfordt S.H., Callery M.P., Meyers W.C., and Chari R.S. Regulation of NFkappaB in hepatic ischemic preconditioning. J. Am. Coll. Surg. 195 3 (2002) 319-326
41. Ruusalepp A., Yan Z.Q., Carlsen H., Czibik G., Hansson G.K., Moskaug J.O., Blomhoff R., and Valen G. Gene deletion of NF-kappaB p105 enhances neointima formation in a mouse model of carotid artery injury. Cardiovasc. Drugs Ther. 20 2 (2006) 103-111
42. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 8 (1991) 2247-2258
43. Shan B., Cai Y.Z., Sun M., and Corke H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J. Agric. Food Chem. 53 20 (2005) 7749-7759
44. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 10 (2003) 768-780
45. Takada Y., Bhardwaj A., Potdar P., and Aggarwal B.B. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23 57 (2004) 9247-9258
46. Teoh N., Dela P.A., and Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 36 1 (2002) 94-102
47. Valen G. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Basic Res. Cardiol. 99 1 (2004) 1-7
48. Valen G., Yan Z.Q., and Hansson G.K. Nuclear factor kappa-B and the heart. J. Am. Coll. Cardiol. 38 2 (2001) 307-314
49. Wang S.Y., Feng R., Bowman L., Penhallegon R., Ding M., and Lu Y. Antioxidant activity in lingonberries (Vaccinium vitis-idaea L.) and its inhibitory effect on activator protein-1, nuclear factor-kappaB, and mitogen-activated protein kinases activation. J. Agric. Food Chem. 53 8 (2005) 3156-3166
50. Wang S.Y., Feng R., Lu Y., Bowman L., and Ding M. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.). J. Agric. Food Chem. 53 10 (2005) 4187-4193
51. Wang S.Y., Zheng W., and Galletta G.J. Cultural system affects fruit quality and antioxidant capacity in strawberries. J. Agric. Food Chem. 50 22 (2002) 6534-6542
52. Yang R.C., Chen H.W., Lu T.S., and Hsu C. Potential protective effect of NF-kappaB activity on the polymicrobial sepsis of rats preconditioning heat shock treatment. Clin. Chim. Acta 302 1-2 (2000) 11-22
53. Zhang J., Ping P., Vondriska T.M., Tang X.L., Wang G.W., Cardwell E.M., and Bolli R. Cardioprotection involves activation of NF-kappa B via PKC-dependent tyrosine and serine phosphorylation of I kappa B-alpha. Am. J. Physiol Heart Circ. Physiol 285 4 (2003) H1753-H1758